Emalex Biosciences

formerly EmalexClosed

Emalex Biosciences

Northbrook, United States · Founded 2018 · $285.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$285.0M
Last Round
$250.0M Series DNov 2022
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Emalex Biosciences was a CNS-focused biopharmaceutical company founded in 2018 by Jeffrey Aronin under parent company Paragon Biosciences, dedicated to developing novel therapies for Tourette syndrome and other neurological disorders. The company advanced a first-in-class investigational compound (ecopipam) through late-stage clinical development, earning recognition as Neuroscience Therapeutics Company of the Year. In June 2026, Teva Pharmaceuticals completed its acquisition of Emalex, adding the NDA-ready asset to Teva's neuroscience pipeline as part of its Pivot to Growth strategy.

Summary

Emalex Biosciences is a Biotech company based in Northbrook, United States, founded in 2018. It has raised $285.0M in total across 4 rounds, most recently a $250.0M Series D round in Nov 2022. Investors include Paragon Biosciences, Bain Capital Life Sciences and Valor Equity Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionVenture RoundJun 2026

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Emalex Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/emalex-biosciences"><img src="https://indexed.vc/api/badge/company/emalex-biosciences" alt="Emalex Biosciences on Indexed.vc" width="260" height="76" /></a>